Short Interest in Cronos Group Inc. (NASDAQ:CRON) Drops By 5.7%

Cronos Group Inc. (NASDAQ:CRON) was the target of a significant drop in short interest in the month of November. As of November 30th, there was short interest totalling 3,450,000 shares, a drop of 5.7% from the November 15th total of 3,660,000 shares. Based on an average daily volume of 1,020,000 shares, the short-interest ratio is currently 3.4 days. Currently, 1.7% of the shares of the company are sold short.

Cronos Group Stock Performance

Shares of NASDAQ CRON traded up $0.01 during midday trading on Tuesday, reaching $1.94. The company’s stock had a trading volume of 309,100 shares, compared to its average volume of 1,850,295. Cronos Group has a fifty-two week low of $1.86 and a fifty-two week high of $3.14. The business’s 50 day moving average price is $2.10 and its two-hundred day moving average price is $2.24. The company has a market cap of $739.74 million, a P/E ratio of -14.85 and a beta of 0.99.

Institutional Investors Weigh In On Cronos Group

A number of hedge funds and other institutional investors have recently made changes to their positions in CRON. National Bank of Canada FI increased its stake in Cronos Group by 1,094.4% in the second quarter. National Bank of Canada FI now owns 15,169 shares of the company’s stock valued at $35,000 after acquiring an additional 13,899 shares during the last quarter. Quantbot Technologies LP bought a new position in Cronos Group in the third quarter valued at approximately $37,000. Headlands Technologies LLC increased its stake in Cronos Group by 12,309.4% in the second quarter. Headlands Technologies LLC now owns 27,797 shares of the company’s stock valued at $65,000 after acquiring an additional 27,573 shares during the last quarter. CIBC Asset Management Inc bought a new position in Cronos Group in the second quarter valued at approximately $87,000. Finally, Cedar Wealth Management LLC increased its stake in Cronos Group by 65.4% in the second quarter. Cedar Wealth Management LLC now owns 37,935 shares of the company’s stock valued at $88,000 after acquiring an additional 15,000 shares during the last quarter. 8.71% of the stock is currently owned by institutional investors and hedge funds.

Cronos Group Company Profile

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.